microbiome
UK, Australian Researchers ID Tumor-Agnostic Microbiome Signature to Predict Opdivo-Yervoy Response
Premium
Researchers uncovered 22 bacteria that could predict which patients do and do not respond to combination checkpoint inhibitors across diverse cancer types.
Eligo Bioscience Raises $30M in Series B Financing to Develop CRISPR-Based Acne Drug
The funding is earmarked to move the topical drug, which aims to edit the skin's microbiome to eliminate certain bacteria, into clinical trials.
Enterome Begins Studies of Microbiome-Derived, Peptide-Based Immunotherapies in Colorectal Cancer
The company has begun dosing patients with EO4010 in the AUDREY trial and is starting a Phase II trial of EO2040 in patients with minimal residual disease.
Investigators are studying why people respond differently to the same foods, with an eye toward developing predictive algorithms based on patient data.
Based on their success treating C. difficile, drugmakers are using different strategies to develop microbiome cancer therapies, including using genomics tools to home in on patient-specific strategies.